These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25600253)

  • 1. Patients' perceived value of pharmacy quality measures: a mixed-methods study.
    Shiyanbola OO; Mort JR
    BMJ Open; 2015 Jan; 5(1):e006086. PubMed ID: 25600253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the Consumer Experience with Pharmacy Services Survey as a quality metric for ambulatory care pharmacies: older adults' perspectives.
    Shiyanbola OO; Mott DA; Croes KD
    BMJ Open; 2016 May; 6(5):e011241. PubMed ID: 27231004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing the use of community pharmacy quality measures: a qualitative study.
    Shiyanbola OO; Mort JR; Lyons K
    J Am Pharm Assoc (2003); 2013; 53(4):400-7. PubMed ID: 23892813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient perceptions of a pharmacy star rating model.
    Warholak TL; Patel M; Rosenthal M; West-Strum D; Ettienne EB; Nunlee-Bland G; Nau D; Hincapie AL
    J Am Pharm Assoc (2003); 2017; 57(3):311-317. PubMed ID: 28285064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural and process aspects of pharmacy quality: older adults' perceptions.
    Shiyanbola OO; Mott DA; Croes KD
    Int J Clin Pharm; 2016 Feb; 38(1):96-106. PubMed ID: 26499502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy patronage: identifying key factors in the decision making process using the determinant attribute approach.
    Franic DM; Haddock SM; Tucker LT; Wooten N
    J Am Pharm Assoc (2003); 2008; 48(1):71-85. PubMed ID: 18192134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System.
    Desai V; Nau D; Conklin M; Heaton PC
    J Manag Care Spec Pharm; 2016 Jul; 22(7):779-86. PubMed ID: 27348278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring consumer understanding and preferences for pharmacy quality information.
    Shiyanbola OO; Mort JR
    Pharm Pract (Granada); 2014 Oct; 12(4):468. PubMed ID: 25580169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Describing the patient experience from Yelp reviews of community pharmacies.
    Lester CA; Wang M; Vydiswaran VGV
    J Am Pharm Assoc (2003); 2019; 59(3):349-355. PubMed ID: 31000435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy performance while providing continuous medication monitoring.
    Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
    J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring patient perspectives on community pharmacy quality: psychometric evaluation of a brief survey.
    Carpenter DM; Roberts CA; Farley JF
    J Manag Care Spec Pharm; 2021 Jan; 27(1):105-111. PubMed ID: 33377440
    [No Abstract]   [Full Text] [Related]  

  • 13. A new model for pharmacies? Insights from a quantitative study regarding the public's perceptions.
    Policarpo V; Romano S; António JHC; Correia TS; Costa S
    BMC Health Serv Res; 2019 Mar; 19(1):186. PubMed ID: 30898124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of perceived service quality and price competitiveness on consumer patronage of and intentions towards community pharmacies.
    Carter SR; Ahmed AM; Schneider CR
    Res Social Adm Pharm; 2023 May; 19(5):717-727. PubMed ID: 36806385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does the public conceptualise the quality of care and its measurement in community pharmacies in the UK: a qualitative interview study.
    Watson MC; Silver K; Watkins R
    BMJ Open; 2019 Mar; 9(3):e027198. PubMed ID: 30928961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient preferences and willingness-to-pay for community pharmacy-led Medicare Part D consultation services: A discrete choice experiment.
    Murry LT; Viyurri B; Chapman CG; Witry MJ; Kennelty KA; Nayakankuppam D; Doucette WR; Urmie J
    Res Social Adm Pharm; 2023 May; 19(5):764-772. PubMed ID: 36710174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices.
    Adeoye-Olatunde OA; Lake LM; Strohmier CA; Gourley AK; Ray AR; Zillich AJ; Snyder ME
    Res Social Adm Pharm; 2021 Aug; 17(8):1407-1419. PubMed ID: 33214124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentially preventable medication-related hospitalizations: A clinical pharmacist approach to assessment, categorization, and quality improvement.
    Pellegrin KL; Lee E; Uyeno R; Ayson C; Goo R
    J Am Pharm Assoc (2003); 2017; 57(6):711-716. PubMed ID: 28823545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of patients' demand for community pharmacies: relationship between pharmacy services and patient satisfaction.
    Kamei M; Teshima K; Fukushima N; Nakamura T
    Yakugaku Zasshi; 2001 Mar; 121(3):215-20. PubMed ID: 11265116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preferences for objective quality metrics during community pharmacy selection: A discrete choice experiment.
    Patterson JA; Holdford DA; Harpe SE
    Res Social Adm Pharm; 2019 Jun; 15(6):641-649. PubMed ID: 30143466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.